HOME >> BIOLOGY >> NEWS
Tracking and treating toxic waste in urban neighborhoods

Abandoned factories and contaminated soil can stall efforts to revive blighted urban neighborhoods. That's because city officials, developers and nearby residents often share common concerns: Is it safe to rebuild here? Will workers and residents become ill from toxic materials that escape into the air and water supplies?

A new research center, led by engineers and scientists at The Johns Hopkins University, plans to address these fears by creating new tools to gauge risks associated with hazardous waste sites and by developing new ways to clean up harmful pollutants. The U.S. Environmental Protection Agency recently approved a five-year $5.2 million grant to launch this new Center for Hazardous Substances in Urban Environments, based at Johns Hopkins. The funds will support research and allow center participants to provide technical help to community groups, state, municipal and local environmental regulators and industry representatives in the Northeast. Researchers from four other institutions the University of Maryland, Morgan State University, the University of Connecticut and the New Jersey Institute of Technology will participate in the new center and share in the EPA grant.

"Before we applied for this grant, we asked regional EPA officials about the most serious challenges they faced," said Ed Bouwer, a Johns Hopkins professor of geography and environmental engineering who serves as the center's director. "One of the top issues they mentioned was urban livability making sure that people in cities have air, water and soil that will not expose them to toxic substances. The other big issue was brownfields abandoned lots and buildings that may contain hazardous materials. If you can redevelop these properties, you can create jobs and improve the tax base. So the cities and states have an economic incentive to promote new construction on the brownfields if the environmental concerns can be addressed."

That's where the new center comes in
'"/>

Contact: Phil Sneiderman
prs@jhu.edu
410-516-7907
Johns Hopkins University
27-Dec-2001


Page: 1 2 3

Related biology news :

1. Tracking climate change
2. Tracking cystic fibrosis with mice
3. Tracking the illegal ivory trade
4. Tracking every egg? AAAS report lists practical options for regulating human cloning
5. School of public health launches CDC Center for Excellence in Environmental Public Health Tracking
6. Satellites vs. mosquitoes: Tracking West Nile Virus in the U.S.
7. Tracking path of virulent bacteria via the web
8. Tracking a genetic basis for alcohol-related hypertension
9. Fat In Spite Of Hard Farm Work - Tracking Down Obesity
10. Tracking A Legacy Of Waste In The West Siberian Basin
11. International Expert To Discuss Ramifications At Local Lecture...Tracking Contaminants In The Mighty Mississippi And Other Large Rivers Worldwide

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Tracking and treating toxic waste urban neighborhoods

(Date:11/21/2014)... According to a new market research report ... Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), End ... - Global Forecasts to 2020", published by MarketsandMarkets, The ... $25 Billion in 2014 and is expected to reach ... 8.69%. Browse 116 market data Tables and ...
(Date:11/21/2014)... JOSE, Calif. , Nov. 20, 2014   ... global leader in microcontroller (MCU) and touch technology solutions, ... digital temperature sensors with the widest V cc ... delivers higher temperature accuracy and faster I 2 C ... registers and serial EEPROM memory making them ideal for ...
(Date:11/18/2014)... YORK , Nov. 18, 2014   ... identity authentication solutions, and MorphoTrust USA ... and services, today announced a strategic partnership to ... enterprise, motor vehicle administration (MVA), airport screening and ... in identity-related solutions, MorphoTrust serves consumers through a ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
(Date:12/17/2014)... Ipsen Biopharmaceuticals, Inc., an affiliate ... IPSEY), today announced that Somatuline® Depot® (lanreotide) ... approved by the U.S. Food and Drug Administration ... (GEP-NETs) in adult patients with unresectable, well or ... improve progression-free survival (PFS). , “The approval of ...
(Date:12/17/2014)... IN (PRWEB) December 17, 2014 ... Laboratory Excellence following its most recent COLA inspection. ... by COLA, a national healthcare accreditation organization. Accreditation ... standards of quality in day-to-day operations, demonstrate continued ... pass a rigorous on-site laboratory survey. ...
(Date:12/17/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... announced the next step in its expanded strategy to ... with the naming of current Chief Operating Officer, ... while current Chairman of the Board and CEO ... These changes are effective January 1, 2015. ...
(Date:12/17/2014)... 17, 2014 Tigercat Pharma, Inc. today ... evaluating the investigational oral NK-1 receptor antagonist VPD-737 ... chronic itch who are unresponsive or inadequately responsive ... steroids and antihistamines. The primary ... Scale (VAS) itch score from baseline, comparing drug ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
Cached News: